Artikel ; Online: Improving therapeutic potential in breast cancer via histone deacetylase inhibitor loaded nanofibrils.
2024 Band 85, Heft 2, Seite(n) e22172
Abstract: Epigenetic modifications play a significant role in cancer progression, making them potential targets for therapy. Histone deacetylase inhibitors have shown promise in inhibiting cancer cell growth, including in breast cancer (BC). In this research, we ... ...
Abstract | Epigenetic modifications play a significant role in cancer progression, making them potential targets for therapy. Histone deacetylase inhibitors have shown promise in inhibiting cancer cell growth, including in breast cancer (BC). In this research, we examined the potential of using suberoyl anilide hydroxamic acid (SAHA)-loaded β-lg nanofibrils as a drug delivery system for triple-negative BC cell lines. We assessed their impact on cell cycle progression, apoptosis, levels of reactive oxygen species, and mitochondrial membrane potential in cancer cells. The combination of SAHA and β-lg nanofibrils demonstrated enhanced efficacy in inhibiting cell growth, inducing cell cycle arrest, and promoting apoptosis (43.78%) compared to SAHA alone (40.09%). Moreover, it effectively targeted cancer cells without promoting drug resistance while using a low concentration of the nanofibrils. These findings underscore the promising potential of nanofibril-based drug delivery systems for BC treatment. |
---|---|
Mesh-Begriff(e) | Humans ; Female ; Histone Deacetylase Inhibitors/pharmacology ; Breast Neoplasms/drug therapy ; Breast Neoplasms/metabolism ; Hydroxamic Acids/pharmacology ; Vorinostat/pharmacology ; Vorinostat/therapeutic use ; Cell Cycle ; Apoptosis ; Cell Proliferation ; Cell Line, Tumor ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use |
Chemische Substanzen | Histone Deacetylase Inhibitors ; Hydroxamic Acids ; Vorinostat (58IFB293JI) ; Antineoplastic Agents |
Sprache | Englisch |
Erscheinungsdatum | 2024-03-15 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article |
ZDB-ID | 604587-x |
ISSN | 1098-2299 ; 0272-4391 |
ISSN (online) | 1098-2299 |
ISSN | 0272-4391 |
DOI | 10.1002/ddr.22172 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Volltext online
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.B 2542: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.